Evaluating Tumor‐Infiltrating Lymphocytes in Breast Cancer
- 21 July 2022
- journal article
- research article
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 42 (3) , 623-634
Abstract
Objectives: Tumor‐infiltrating lymphocytes (TILs) have emerged as an efficient biomarker predicting treatment response and prognosis of breast cancer (BC). This study aimed to evaluate the association between conventional ultrasound and contrast‐enhanced ultrasound (CEUS) imaging features with TIL levels in invasive BC patients.Methods: We retrospectively included 267 women with invasive BC who had undergone conventional ultrasound and CEUS. Patients were divided into low (≤10%) and high (>10%) TIL groups. Conventional ultrasound and CEUS features were analyzed by two sonographers. The associations between the TIL levels and imaging features were evaluated.Results: Of the 267 patients, 122 with high TILs and 145 with low TIL levels. High TIL tumors were more likely to have a circumscribed margin, oval or round shape, and enhanced posterior echoes on ultrasonography (p < 0.05). In contrast, low TIL tumors were more likely to have an irregular shape, un‐circumscribed, indistinct and spiculated margin (p < 0.05). In CEUS, high TIL tumors showed a more regular shape, clearer margin, more homogeneous enhancement and higher peak intensity (PI) value (p < 0.05). Logistic analysis indicated that shape, posterior features, PI, and enhanced homogeneity were independent predictors for high TIL tumors. The model combined the four independent predictors have a moderate performance in predicting high TIL tumors with AUC 0.79, sensitivity 0.72, and specificity 0.78.Conclusions: Conventional ultrasound and CEUS features were associated with TIL levels in invasive BC. Consequently, the results suggested that preoperative conventional ultrasound and CEUS may be a useful noninvasive imaging biomarker for individualized treatment decisions.Keywords
This publication has 32 references indexed in Scilit:
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerSeminars in Cancer Biology, 2018
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapyThe Lancet Oncology, 2018
- Predicting the level of tumor‐infiltrating lymphocytes in patients with triple‐negative breast cancer: Usefulness of breast MRI computer‐aided detection and diagnosisJournal of Magnetic Resonance Imaging, 2017
- Correlation Between MRI and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast CancerAmerican Journal of Roentgenology, 2016
- Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound—a preliminary study in ChinaEuropean Radiology, 2016
- Differentiation of Benign and Malignant Sub‐1‐cm Breast Lesions Using Contrast‐Enhanced SonographyJournal of Ultrasound in Medicine, 2015
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Prognostic Role of MRI Enhancement Features in Patients With Breast Cancer: Value of Adjacent Vessel Sign and Increased Ipsilateral Whole-Breast VascularityAmerican Journal of Roentgenology, 2012
- Sensitivity and Specificity of Unilateral Edema on T2w-TSE Sequences in MR-Mammography Considering 974 Histologically Verified LesionsThe Breast Journal, 2010
- Differences in the attenuation of ultrasound by normal, benign, and malignant breast tissueJournal of Clinical Ultrasound, 1976